Neutrophil to lymphocyte ratio as an assessment tool to differentiate between uterine sarcoma and myoma: a systematic review and meta-analysis

Bibliographic Details
Title: Neutrophil to lymphocyte ratio as an assessment tool to differentiate between uterine sarcoma and myoma: a systematic review and meta-analysis
Authors: Fatemeh Tabatabaei, Saghar Babadi, Shima Nourigheimasi, Arshin Ghaedi, Monireh Khanzadeh, Aida Bazrgar, Morad Kohandel Gargari, Shokoufeh Khanzadeh
Source: BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Publisher Information: BMC, 2024.
Publication Year: 2024
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neutrophil to lymphocyte ratio, NLR, Uterine sarcoma, Uterine leiomyoma, Meta-analysis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background This systematic review and meta-analysis aimed to determine the potential value of neutrophil to lymphocyte ratio (NLR) as an assessment tool in the clinical distinction between uterine sarcoma and uterine leiomyoma. Methods We comprehensively searched Web of Science, Scopus, and PubMed for relevant papers published before March 19, 2023. The standardized mean difference (SMD) was provided, along with a 95% confidence interval (CI). The random-effects model was employed to derive pooled effects due to the high levels of heterogeneity. The Newcastle-Ottawa scale was used for the quality assessment. Our study was registered in PROSPERO (CRD42023478331). Results Overall, seven articles were included in the analysis. A random-effect model revealed that patients with uterine sarcoma had higher NLR levels compared to those with uterine myoma (SMD = 0.60, 95% CI = 0.22–0.98; p = 0.002). In the subgroup analysis according to sample size, we found that patients with uterine sarcoma had elevated levels of NLR compared to those with uterine myoma in either large studies (SMD = 0.58, 95% CI = 0.04–1.13; P
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1471-2407
68048661
Relation: https://doaj.org/toc/1471-2407
DOI: 10.1186/s12885-023-11775-5
Access URL: https://doaj.org/article/ba7c39d919c34addb6cd5f680486616d
Accession Number: edsdoj.ba7c39d919c34addb6cd5f680486616d
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14712407
68048661
DOI:10.1186/s12885-023-11775-5
Published in:BMC Cancer
Language:English